VBI Gross Profit vs Other Operating Expenses Analysis
VBIV Stock | USD 0.56 0.01 1.75% |
VBI Vaccines financial indicator trend analysis is much more than just breaking down VBI Vaccines prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether VBI Vaccines is a good investment. Please check the relationship between VBI Vaccines Gross Profit and its Other Operating Expenses accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VBI Vaccines. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.
Gross Profit vs Other Operating Expenses
Gross Profit vs Other Operating Expenses Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of VBI Vaccines Gross Profit account and Other Operating Expenses. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between VBI Vaccines' Gross Profit and Other Operating Expenses is -0.37. Overlapping area represents the amount of variation of Gross Profit that can explain the historical movement of Other Operating Expenses in the same time period over historical financial statements of VBI Vaccines, assuming nothing else is changed. The correlation between historical values of VBI Vaccines' Gross Profit and Other Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Gross Profit of VBI Vaccines are associated (or correlated) with its Other Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Operating Expenses has no effect on the direction of Gross Profit i.e., VBI Vaccines' Gross Profit and Other Operating Expenses go up and down completely randomly.
Correlation Coefficient | -0.37 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Gross Profit
Gross profit is a required income statement account that reflects total revenue of VBI Vaccines minus its cost of goods sold. It is profit before VBI Vaccines operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of VBI Vaccines. It is also known as VBI Vaccines overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most indicators from VBI Vaccines' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into VBI Vaccines current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VBI Vaccines. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.At this time, VBI Vaccines' Selling General Administrative is fairly stable compared to the past year. Issuance Of Capital Stock is likely to climb to about 35.9 M in 2024, whereas Enterprise Value Over EBITDA is likely to drop (0.76) in 2024.
2023 | 2024 (projected) | Non Recurring | 5.7M | 5.0M | Reconciled Depreciation | 2.0M | 1.6M |
VBI Vaccines fundamental ratios Correlations
Click cells to compare fundamentals
VBI Vaccines Account Relationship Matchups
High Positive Relationship
High Negative Relationship
VBI Vaccines fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 122.2M | 209.4M | 210.3M | 155.1M | 87.0M | 73.5M | |
Total Stockholder Equity | 88.3M | 171.7M | 143.9M | 64.2M | 7.5M | 7.2M | |
Property Plant And Equipment Net | 10.2M | 10.7M | 11.0M | 12.3M | 11.9M | 21.9M | |
Net Debt | (29.4M) | (92.9M) | (89.9M) | (10.4M) | 29.4M | 30.8M | |
Retained Earnings | (262.4M) | (308.6M) | (378.4M) | (489.6M) | (582.4M) | (553.3M) | |
Cash | 44.2M | 93.8M | 121.7M | 62.6M | 23.7M | 28.9M | |
Non Current Assets Total | 75.2M | 77.3M | 80.0M | 77.4M | 50.7M | 42.9M | |
Non Currrent Assets Other | 2.1M | 2.2M | 4.6M | 4.7M | 1.2M | 992.6K | |
Cash And Short Term Investments | 44.2M | 119.1M | 121.7M | 62.6M | 23.7M | 31.5M | |
Common Stock Shares Outstanding | 4.0M | 7.3M | 8.5M | 8.6M | 15.6M | 16.4M | |
Liabilities And Stockholders Equity | 122.2M | 209.4M | 210.3M | 155.1M | 87.0M | 73.5M | |
Other Current Assets | 450K | 1.3M | 2.2M | 8.4M | 2.8M | 2.9M | |
Other Stockholder Equity | 66.4M | 75.5M | 81.6M | 90.0M | 107.4M | 112.8M | |
Total Liab | 33.9M | 37.7M | 66.4M | 90.9M | 79.4M | 83.4M | |
Property Plant And Equipment Gross | 11.7M | 12.3M | 19.3M | 23.6M | 22.3M | 27.7M | |
Total Current Assets | 47.0M | 132.0M | 130.3M | 77.7M | 36.2M | 33.0M | |
Total Current Liabilities | 29.8M | 17.3M | 32.6M | 36.9M | 75.7M | 79.5M | |
Accounts Payable | 1.1M | 3.7M | 4.3M | 13.0M | 6.4M | 6.8M | |
Net Receivables | 201K | 77K | 8K | 94K | 1.3M | 1.3M | |
Non Current Liabilities Total | 4.2M | 20.3M | 33.8M | 54.0M | 3.7M | 3.5M | |
Accumulated Other Comprehensive Income | (752K) | 1.3M | (1.6M) | 21.4M | 28.3M | 29.7M | |
Other Assets | 620K | 2.2M | 1.3M | 1.4M | 1.0 | 0.95 | |
Short Long Term Debt Total | 14.8M | 944K | 31.8M | 52.2M | 53.0M | 55.7M | |
Inventory | 1.1M | 2.2M | 2.6M | 6.6M | 8.5M | 8.9M | |
Other Current Liab | 12.9M | 12.4M | 26.9M | 22.6M | 6.7M | 5.7M | |
Short Term Debt | 14.8M | 944K | 839K | 972K | 51.7M | 54.3M | |
Common Stock Total Equity | 285.0M | 403.5M | 442.2M | 442.3M | 508.7M | 260.5M | |
Common Stock | 285.0M | 403.5M | 442.2M | 442.3M | 454.2M | 247.1M | |
Net Tangible Assets | 25.3M | 107.3M | 79.5M | 3.7M | 4.2M | 4.0M | |
Current Deferred Revenue | 882K | 255K | 526K | 409K | 10.9M | 11.4M | |
Intangible Assets | 60.8M | 62.2M | 62.1M | 58.3M | 36.5M | 47.5M | |
Property Plant Equipment | 11.7M | 10.7M | 11.0M | 12.3M | 14.1M | 14.8M | |
Other Liab | 3.4M | 3.4M | 2.9M | 2.7M | 3.1M | 2.7M | |
Short Long Term Debt | 1.6M | 1.1M | 14.8M | 50.8M | 58.4M | 61.3M | |
Capital Surpluse | 66.4M | 75.5M | 81.6M | 90.0M | 103.5M | 75.2M | |
Good Will | 8.3M | 2.2M | 2.3M | 2.1M | 1.1M | 1.1M | |
Retained Earnings Total Equity | (262.4M) | (308.6M) | (378.4M) | (489.6M) | (440.6M) | (418.6M) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards VBI Vaccines in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, VBI Vaccines' short interest history, or implied volatility extrapolated from VBI Vaccines options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether VBI Vaccines is a strong investment it is important to analyze VBI Vaccines' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact VBI Vaccines' future performance. For an informed investment choice regarding VBI Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VBI Vaccines. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for VBI Stock analysis
When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Transaction History View history of all your transactions and understand their impact on performance | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is VBI Vaccines' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VBI Vaccines. If investors know VBI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VBI Vaccines listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.03) | Revenue Per Share 0.558 | Quarterly Revenue Growth 1.911 | Return On Assets (0.29) | Return On Equity (2.59) |
The market value of VBI Vaccines is measured differently than its book value, which is the value of VBI that is recorded on the company's balance sheet. Investors also form their own opinion of VBI Vaccines' value that differs from its market value or its book value, called intrinsic value, which is VBI Vaccines' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VBI Vaccines' market value can be influenced by many factors that don't directly affect VBI Vaccines' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VBI Vaccines' value and its price as these two are different measures arrived at by different means. Investors typically determine if VBI Vaccines is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VBI Vaccines' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.